Caplight Directory>Investors>Oncode Institute>Oncode-institute


Oncode Institute

Oncode Institute

Utrechtoncodeinstitute.nl

Overview

Oncode Institute is a Dutch cancer research and innovation organization that provides pre-seed and seed investments to oncology-focused spin-off companies through its Oncode Oncology Bridge Fund.

Year Founded

2017

Portfolio Companies

1

Investments

CompanyDateStageLead
Single Cell DiscoveriesSep 2018SeedLead

Key People

René Kuijten

Initiator & Founder, Vice-chairman Supervisory Board

Carolien Hovenier

Patient Partner

Gerrit Oostenveld

Patient Partner

Anne Rios

Principal Investigator

Jacco van Rheenen

Principal Investigator

Jop Kind

Principal Investigator

Lodewyk Wessels

Oncode Principal Investigator

Louis Vermeulen

Principal Investigator

Madelon Maurice

Principal Investigator

Mario van der Stelt

Principal Investigator

Miao-Ping Chien

Principal Investigator

Rebekka K. Schneider

Principal Investigator

Ruben van Boxtel

Principal Investigator At The Princess Máxima Center And Oncode Institute

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersUtrecht
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.